69.26
Schlusskurs vom Vortag:
$68.42
Offen:
$68.17
24-Stunden-Volumen:
2.33M
Relative Volume:
0.51
Marktkapitalisierung:
$24.07B
Einnahmen:
$19.12B
Nettoeinkommen (Verlust:
$3.55B
KGV:
7.4598
EPS:
9.2844
Netto-Cashflow:
$9.85B
1W Leistung:
+4.92%
1M Leistung:
+3.88%
6M Leistung:
-2.97%
1J Leistung:
+58.09%
Synchrony Financial Stock (SYF) Company Profile
Firmenname
Synchrony Financial
Sektor
Branche
Telefon
203 585-2400
Adresse
777 LONG RIDGE ROAD, STAMFORD
Compare SYF vs V, MA, AXP, COF, PYPL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SYF
Synchrony Financial
|
69.26 | 23.78B | 19.12B | 3.55B | 9.85B | 9.2844 |
|
V
Visa Inc
|
303.33 | 578.51B | 41.39B | 20.59B | 22.93B | 10.55 |
|
MA
Mastercard Incorporated
|
501.50 | 440.06B | 32.84B | 14.97B | 16.19B | 16.52 |
|
AXP
American Express Co
|
305.73 | 205.86B | 80.49B | 10.76B | 16.08B | 15.38 |
|
COF
Capital One Financial Corp
|
184.21 | 113.14B | 69.28B | 2.01B | 26.14B | 2.9491 |
|
PYPL
Paypal Holdings Inc
|
45.48 | 41.74B | 33.34B | 5.23B | 5.56B | 5.4094 |
Synchrony Financial Stock (SYF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2026-01-28 | Hochstufung | Compass Point | Neutral → Buy |
| 2025-12-08 | Fortgesetzt | Wolfe Research | Outperform |
| 2025-12-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-10-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-10-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-07-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-04-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-28 | Herabstufung | Compass Point | Buy → Neutral |
| 2025-01-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-12-19 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2024-12-09 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-12-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-07-16 | Eingeleitet | Compass Point | Buy |
| 2024-06-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-06-07 | Eingeleitet | BTIG Research | Buy |
| 2024-05-02 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-04-04 | Hochstufung | Wolfe Research | Underperform → Outperform |
| 2024-02-08 | Fortgesetzt | Morgan Stanley | Underweight |
| 2024-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-01-10 | Eingeleitet | Deutsche Bank | Buy |
| 2023-11-15 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-01 | Eingeleitet | TD Cowen | Outperform |
| 2023-10-13 | Eingeleitet | HSBC Securities | Hold |
| 2023-09-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-03-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-03-17 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-01-06 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-13 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-01 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Eingeleitet | UBS | Neutral |
| 2022-07-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-12 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2022-04-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-17 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-01-31 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Morgan Stanley | Overweight |
| 2022-01-31 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-31 | Bestätigt | Seaport Research Partners | Buy |
| 2022-01-31 | Bestätigt | Stephens | Equal-Weight |
| 2022-01-03 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-29 | Eingeleitet | Piper Sandler | Neutral |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-08-30 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-07-09 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-04-09 | Eingeleitet | Evercore ISI | Outperform |
| 2021-01-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-10 | Eingeleitet | Deutsche Bank | Buy |
| 2020-07-31 | Eingeleitet | Wolfe Research | Outperform |
| 2020-07-15 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-27 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-12-05 | Herabstufung | Nomura | Buy → Neutral |
| 2019-12-02 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-05-03 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-02-14 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-30 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-24 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-01-03 | Hochstufung | Stephens | Underweight → Equal-Weight |
| 2018-09-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-04-17 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-04-05 | Eingeleitet | Citigroup | Neutral |
| 2018-03-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-01-09 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2017-12-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-10-11 | Fortgesetzt | Wells Fargo | Market Perform |
Alle ansehen
Synchrony Financial Aktie (SYF) Neueste Nachrichten
Barclays Lowers Price Target for SYF, Maintains Overweight Ratin - gurufocus.com
Synchrony Financial (NYSE:SYF) Price Target Cut to $82.00 by Analysts at Barclays - MarketBeat
Synchrony Financial earnings preview: What to expect - MSN
Stereotaxis Shares Rise on FDA Clearance for Synchrony - marketscreener.com
Seaport Global Adjusts Price Target on Synchrony Financial to $84 From $95, Maintains Buy Rating - marketscreener.com
Synchrony Financial Earnings Preview: What to Expect - Yahoo Finance
Stereotaxis Announces FDA Clearance and Launch of Synchrony System - GlobeNewswire
Synchrony Puts Teachers First This Financial Literacy Month with $2 Million Commitment to Bring Training, Tools, and Financial Literacy Labs to U.S. High Schools - StreetInsider
Barclays Adjusts Price Target on Synchrony Financial to $82 From $93, Maintains Overweight Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Synchrony Financial to $80 From $88, Maintains Outperform Rating - marketscreener.com
Aberdeen Group plc Has $25.01 Million Holdings in Synchrony Financial $SYF - MarketBeat
Best CD Rates Of April 2026: Up To 4.35% APY - Forbes
10 Best High-Yield Savings Accounts Of April 2026: Up to 5.00% APY - Forbes
Sovran Advisors LLC Has $4.26 Million Stake in Synchrony Financial $SYF - MarketBeat
Synchrony Financial R (SFE.F) Q1 FY2025 earnings call transcript - Yahoo Finance
Synchrony Financial executive sells $293k in stock - Investing.com
Synchrony Financial (NYSE:SYF) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Synchrony Financial (SYF) director receives 883 restricted stock units grant - Stock Titan
Synchrony Financial (NYSE: SYF) director granted 883 restricted stock units - Stock Titan
Synchrony Financial (SYF) director receives 1,343 restricted stock units - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units vesting in 2027 - Stock Titan
Synchrony Financial (NYSE: SYF) director awarded 883 restricted stock units - Stock Titan
Director Ellen Zane granted 883 RSUs at Synchrony (NYSE: SYF) - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units - Stock Titan
Director at Synchrony (NYSE: SYF) receives 883 RSUs vesting 2027 - Stock Titan
Synchrony Financial (SYF) director receives 883 RSUs - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units vesting 2027 - Stock Titan
Director Parker receives 883 RSUs in Synchrony Financial (NYSE: SYF) - Stock Titan
Stock Traders Buy High Volume of Synchrony Financial Put Options (NYSE:SYF) - MarketBeat
What Is Synchrony Bank, and Are Its Credit Cards Right for You? - NerdWallet
Synchrony Financial EVP Schaller sells $878875 in stock - investing.com
Synchrony Bank Login: Access Your Account - GOBankingRates
How Synchrony’s Expanded Pet-Health Reimbursement Network Could Shape Synchrony Financial (SYF) Investors’ View - simplywall.st
Why innovation never sleeps at Synchrony - linkedin.com
Veterans Say Synchrony Arbitration Order Defies MLA - Law360
10 Best Online Banks - Forbes
Stamford-Based Synchrony Named Best Workplace in US, Beating Out Major Brands - dailyvoice.com
Stamford-based Synchrony recognized as No. 1 'Best Company to Work For' - Yahoo Finance
Synchrony Bank Review: Pros, Cons, And Alternatives - The College Investor
10 best high-yield savings accounts for April 2026: Earn up to 4.10% APY - Yahoo Finance
Synchrony Named No. 1 Best Company to Work For in the U.S., Powered by a High-Trust Culture that Fuels Innovation - PR Newswire
Vaughan Nelson Investment Management L.P. Sells 226,705 Shares of Synchrony Financial $SYF - MarketBeat
Announcing the 2026 Fortune 100 Best Companies to Work For - GlobeNewswire Inc.
From flexible Fridays to AI partners: Synchrony Financial leads the 2026 Fortune 100 Best Companies To Work For list - Fortune
Synchrony Bank CD Rates for April 2026 - GOBankingRates
Prior Loss Dooms Robocall Blocker's Fight With Synchrony - Law360
Synchrony Financial stock outperforms competitors on strong trading day - marketwatch.com
The real engine of innovation is trust - Fortune
Truist Lowers Synchrony Financial (SYF) Price Target to $71 - Insider Monkey
TD Cowen Adjusts Price Target on Synchrony Financial to $83 From $95, Maintains Buy Rating - MarketScreener
Synchrony Premier World Mastercard® - Credit Karma
Finanzdaten der Synchrony Financial-Aktie (SYF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Synchrony Financial-Aktie (SYF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schaller Bart | See remarks |
Mar 02 '26 |
Sale |
67.71 |
12,980 |
878,876 |
34,035 |
| Juel Carol | See remarks |
Mar 02 '26 |
Sale |
67.71 |
16,859 |
1,141,523 |
51,446 |
| Howse Curtis | See remarks |
Mar 02 '26 |
Sale |
67.71 |
7,882 |
533,690 |
94,873 |
| Owens Darrell | See remarks |
Mar 02 '26 |
Sale |
67.71 |
3,865 |
261,699 |
17,432 |
| Wenzel Brian J. Sr. | See remarks |
Mar 03 '26 |
Sale |
67.16 |
47,112 |
3,164,042 |
64,221 |
| Wenzel Brian J. Sr. | See remarks |
Mar 02 '26 |
Sale |
67.71 |
19,580 |
1,325,762 |
111,333 |
| Casellas Alberto | See remarks |
Mar 02 '26 |
Sale |
67.71 |
14,399 |
974,956 |
50,331 |
| DOUBLES BRIAN D | See remarks |
Mar 02 '26 |
Option Exercise |
33.85 |
67,554 |
2,286,991 |
868,327 |
| DOUBLES BRIAN D | See remarks |
Mar 02 '26 |
Sale |
68.68 |
217,554 |
14,941,869 |
829,222 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):